Telemedicine Interventional Therapy, Extra-cavity LV Image Registration…
1Department of Cardiology, Ankara University Faculty of Medicine, İbn-i Sina Hospital, Ankara, Türkiye
Anatol J Cardiol 2024; 4(28): 176-176 PubMed ID: 38551222 PMCID: 11017682 DOI: 10.14744/AnatolJCardiol.2024.4
Full Text PDF

CONTENT

Although telemedicine interventional therapy is an innovative method to reduce public medical burden and improve heart failure, Its effectiveness is still controversial. Wang et al from China evaluated in this meta-analysis the role of telemedicine interventional therapy in the treatment of patients with chronic heart failure.

Intraluminal thrombi in the abdominal aortic aneurysm (AAA)s were demonstrated to increase aneurysm growth. The effect of treatments on thrombus reduction upon AAA enlargement and clinical endpoints is uncertain. Therefore, Erdem Yaman and Poyraz from Türkiye aimed to investigate the effect of antiplatelet and anticoagulant therapy on AAA growth and clinical outcomes.

Zuo et al from China investigated the influence of aging on the effectiveness and tolerance of sacubitril/valsartan among hypertensive patients complicated with heart failure in a real-world setting. Clinically useful findings.

Computed tomography image integration is of limited use in left ventricular (LV) ablation due to inadequate accuracy of registration. The current study by Li et al from China aims to investigate the accuracy and feasibility of extra-cavity LV image registration via the coronary cusp. New innovation?

Cardiovascular events (MACE) are more common in Type 2 Diabetes Mellitus (T2DM) patients and early diagnosis can prevent significant morbidity and mortality. Çetin et al from Türkiye studied fragmented QRS as a predictor of cardiovascular events in patients with T2DM: a 36-months follow-up data in T2DM patients.

And letters, e-page originals…

I hope this new issue of our journal will be interest of our reader